Winicker-Norimed Medizinische Forschung GmbH

Nephrology and Chronic Kidney Disease

Research activity is centered on stage 3 chronic kidney disease, with attention to renal function preservation and disease progression in people with impaired kidney health.

  • Renal protection
  • Kidney function preservation
  • Chronic kidney disease

The therapeutic focus includes interventions relevant to glucose handling in the kidney and maintenance of renal excretion patterns associated with kidney-directed treatment.

Metabolic Renal Therapy

The sponsor’s clinical work also reflects interest in therapies that intersect metabolic regulation and kidney disease management, particularly where treatment effects influence renal glucose excretion.

  • Renal glucose excretion
  • Metabolic control
  • Kidney-targeted therapy

Its research landscape includes evaluation of treatment combinations relevant to diabetic kidney disease pathways and broader renal metabolic support.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Dapagliflozin and Balcinrenone for Patients Over 50 with Stage 3 Chronic Kidney Disease

    Not recruiting

    1 1
    France Germany